News & Press Releases

Law360 Healthcare Authority featured insights from Member Theresa Carnegie in an article focused on the Consolidated Appropriations Act of 2026 which introduces new regulations for pharmacy benefit managers, particularly aimed at fee and cost transparency.

The American Lawyer featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan. The article highlights the team’s focus on high-stakes disputes, including representing major corporations in antitrust opt-out cases, and explains why Mintz was the right fit.

Reuters featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan.

Joanne Hawana was quoted by Endpoints News in an article about how the pharma industry continues to spend hundreds of millions of dollars on ads despite a significant FDA crackdown on misleading consumer ads.  

Member Joanne Hawana was quoted in a Reuters article about the FDA’s plans to restrict GLP-1 ingredients in non-approved compound drugs. The article reports on the agency’s potential enforcement actions involving Hims & Hers and broader regulatory scrutiny of compounded weight-loss medications.

The National Law Journal highlighted the addition of Robert Vlasis to Mintz. He joins as a Co-chair of the firm’s International Trade Commission practice, further strengthening the firm's intellectual property services.